differences < different < differential

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 75.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000010 (2011)	Katsuaki Kanbe [Japon] ; Atsushi Nakamura [Japon] ; Yasuo Inoue [Japon] ; Kaori Hobo [Japon]	Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis
000087 (2011)	K. Krüger [Allemagne] ; B. Hellmich [Allemagne] ; A. Rubbert-Roth [Allemagne] ; U. Müller-Ladner [Allemagne] ; A. Kielhorn [Allemagne]	Ist der Vergleich verschiedener Studien zur Wirksamkeit von Biologika bei Patienten mit rheumatoider Arthritis möglich?
000104 (2012)	Anshuman P. Malaviya [Royaume-Uni, Niger] ; Andrew J. K. Östör [Royaume-Uni]	Rheumatoid arthritis and the era of biologic therapy
000105 (2012)	M. Gallego-Galisteo ; A. Villa-Rubio ; E. Alegre-Del Rey [Espagne] ; E. Márquez-Fernández ; J. J. Ramos-Báez	Indirect comparison of biological treatments in refractory rheumatoid arthritis
000161 (2013)	I. Kötter [Allemagne] ; J. C. Henes [Allemagne]	Etablierte Medikamente
000186 (2010)	Christoph Strehblow [Autriche] ; Guenther Haberhauer [Autriche] ; Peter Fasching [Autriche]	Comparison of different biologic agents in patients with rheumatoid arthritis after failure of the first biologic therapy
000189 (2013)	Diogo Mendes [Portugal] ; Carlos Alves [Portugal] ; Francisco Batel Marques [Portugal]	Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events
000214 (2012)	Fatma Alibaz-Oner [Turquie] ; Sibel Zehra Aydin [Turquie] ; Haner Direskeneli [Turquie]	Advances in the diagnosis, assessment and outcome of Takayasu’s arteritis
000246 (2011)	Bernard Bannwarth [France]	Prise en charge thérapeutique de l’inflammation d’origine rhumatismale
000296 (2012)	Adel Alawadhi [Koweït] ; Khaldoon Alawneh [Jordanie] ; Zeyad Ahmed Alzahrani [Arabie saoudite]	The effect of neutralizing antibodies on the sustainable efficacy of biologic therapies: what’s in it for African and Middle Eastern rheumatologists
000297 (2011)	A. Schwarting [Allemagne]	Nierenbeteiligung beim systemischen Lupus erythematodes
000465 (2012)	Yiping Hu [République populaire de Chine] ; Wenxiang Cheng [République populaire de Chine] ; Wenhong Cai [République populaire de Chine] ; Ye Yue [République populaire de Chine] ; Jinchao Li [République populaire de Chine] ; Peng Zhang [République populaire de Chine]	Advances in research on animal models of rheumatoid arthritis
000530 (2011)	Dimitrios Christidis [Royaume-Uni] ; Shaifali Jain [Royaume-Uni] ; Bhaskar Das Gupta [Royaume-Uni]	Successful use of tocilizumab in polymyalgic onset biopsy positive GCA with large vessel involvement
000539 (2013)	J. Smolen [Autriche] ; M. Dougados [France] ; C. Gaillez ; C. Poncet [France] ; M. Le Bars ; A. Elegbe ; M. Schiff [États-Unis]	AB0543 Remission using different composite disease indices in MTX-IR RA patients treated with abatacept or infliximab, +MTX
000576 (2013)	Marco Bigoni [Italie] ; Paola Sacerdote [Italie] ; Marco Turati [Italie] ; Silvia Franchi [Italie] ; Marta Gandolla [Italie] ; Diego Gaddi [Italie] ; Sarah Moretti [Italie] ; Daniele Munegato [Italie] ; Carlo A. Augusti [Italie] ; Elena Bresciani [Italie] ; Robert J. Omeljaniuk [Canada] ; Vittorio Locatelli [Italie] ; Antonio Torsello [Italie]	Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury
000603 (2013)	A. S. Avdeeva ; E. N. Alexandrova ; E. Y. Panasyuk ; G. V. Lukina ; E. L. Nasonov [Russie]	AB0509 Comparative effectiveness of tocilizumab (TCZ) and rituximab (RTM) using different disease activity indices (DAS 28, SDAI and CDAI) in patients with rheumatoid arthritis (RA)
000611 (2013)	K. Saito [Japon] ; K. Hanami [Japon] ; S. Hirata [Japon] ; S. Kubo [Japon] ; M. Nawata [Japon] ; K. Yamaoka [Japon] ; S. Nakayamada [Japon] ; K. Nakano [Japon] ; Y. Tanaka [Japon]	FRI0251 Comparison of lipid profile including high molecular weight adiponectin (HMW-AN) after treatment with three different biologics in the patients with bio-naïve rheumatoid arthritis (RA)
000632 (2013)	S. Manrique-Arija ; A. Fernandez-Nebro [Espagne] ; V. Coret ; L. Nieves ; V. Rodriguez-García ; C. M. Romero-Barco ; I. Ure A ; F. Jimenez-Nu Ez ; L. Cano ; M. A. Belmonte ; M. V. Irigoyen	AB0331 Analysis of the effectiveness of different doses of rituximab in a cohort of patients with rheumatoid arthritis
000699 (2012)	Young Ho Lee [Corée du Sud] ; Sang-Cheol Bae [Corée du Sud] ; Sung Jae Choi [Corée du Sud] ; Jong Dae Ji [Corée du Sud] ; Gwan Gyu Song [Corée du Sud]	The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis
000805 (2013)	F. Speth [Allemagne] ; N. Wellinghausen [Allemagne] ; J.-P. Haas [Allemagne]	Medikamentöse Prophylaxe während intensivierter Immunsuppression bei Kindern und Jugendlichen
000817 (2010)	Afshin Borhani Haghighi [Iran] ; Anahid Safari [Iran]	Proposing an algorithm for treatment of different manifestations of neuro-Behcet’s disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "different" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "different" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    different
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021